Associated Papers
Tranilast directly targets NLRP3 to treat inflammasome-driven diseases.
Huang Y et al.
Embo Molecular Medicine, 2018
Inflammasome-associated nucleotide-binding domain, leucine-rich repeat proteins and inflammatory diseases.
Jha S et al.
Journal of Immunology (baltimore, Md. : 1950), 2009
Select a paper to view details